Bill Hogan

I've been discussing a similar issue with Chris Stoeckert on the Apollo-SV listserv: https://github.com/ApolloDev/apollo-sv/issues/199 We're happy to model human activity in OMRSE, perhaps as some subtype of planned process. On...

+1 I support this approach. Matt, Clint, and I have done some work defining “human activity” but it has already been criticized on at least one issue thread (for some...

Agree. They are not the same. Certain compulsive behaviors are not programmed nor are they planned. They are closely related and teasing out the distinctions will be important. On Tue,...

+1 On Sun, Aug 4, 2019 at 11:50 AM bpeters42 wrote: > I think a good deciding principle could be that any class that we can only > define as...

I was told at ICBO 2009 that indeed "investigation" covered everything done in clinical medicine: clinical laboratory tests, radiological studies, etc, etc. So I have been, as a result, firmly...

Chris, assuming you were referring to my comment, I was reacting to this sentence (emphasis mine) from Bjorn's email, where he says things happen in clinical medicine without them being...

The dcterms standard itself says not to use literals, or at least Dublin Core user guide says this. See here: https://www.dublincore.org/resources/userguide/publishing_metadata/#exrih1 From the document linked above: "dcterms:contributor must not be...

I 100% support an annotation property in OMO called 'brand name' (we can do without caps and underscores). I just don't think it is right to call it a "synonym...

Some issues: 1. Neither paracetamol nor acetaminophen is a brand name. I just want to clarify that because it seems like that issue is being confused with brand name 2....

I would think re: #3 it should be n > 1 or n >= 1 On Mon, Aug 7, 2023 at 10:35 PM Clint Dowland ***@***.***> wrote: > This concerns...